Follow Us:
Monday, August 03, 2020



In cells, extracts from seaweed outdo remdesivir against virus

July 25, 2020 7:30 am

The research, published online in Cell Discovery, was done by researchers at the Center for Biotechnology and Interdisciplinary Studies at Rensselear Polytechnic Institute, US.

Covid antibodies fade rapidly, raising risk of lost immunity

July 22, 2020 10:00 am

The researchers found that antibody levels fell quickly, with a half-life of about 73 days between the two time frames. The loss of antibodies occurred more quickly than with SARS, an earlier type of coronavirus infection.

Seven arrested for selling Remdesivir injections at five times the MRP

July 20, 2020 1:15 am

Food and Drug and Administration (FDA) Inspector Sharadchandra Nandekar approached Unit 7 of the Mumbai Police Crime Branch after receiving information that a man was selling vials of the injections for Rs 30,000 each.

Punjab hospitals avoid Remdesivir use, settle for cheaper treatment

July 16, 2020 11:19 am

The cost of the injection and even its results still being under scrutiny are a major factor that most Punjab hospitals are avoiding its use.

Explained: What works (and does not) in Covid treatment

July 15, 2020 10:23 am

Experts Explain ~ Drugs used in Covid-19 treatment: As cases and deaths rise, doctors have been trying out a range of treatments. Based on current evidence and what scientists say, here’s a compendium of what works (or doesn’t) — and in what specific circumstances

Tocilizumab in high demand in Mumbai, but short supply as Covid-19 cases surge

July 11, 2020 10:41 pm

Tocilizumab and Remdesivir, two drugs that are still undergoing trials as possible treatment for Covid-19, are in huge demand. Doctors increasingly prescribe it for moderately to severely ill patients even as scientific evidence on their efficacy is awaited.

Explained Ideas: Why dexamethasone, not remdesivir, deserves India's attention for Covid treatment

July 11, 2020 5:00 pm

Dexamethasone is proving to be far more effective in reducing the risk of death and can be made readily available to patients at affordable prices, writes Ganesan Karthikeyan.

There is an irrational preference for expensive Covid treatments over effective ones

July 10, 2020 9:22 am

In the absence of adequate information, the price of a commodity serves as an indicator of quality for the consumer. Information asymmetry is most acute in healthcare, with the added disadvantage that the providers of care have far greater access to, and understanding of the information.

Cipla set to undercut rivals with generic remdesivir for Covid treatment: Sources

July 09, 2020 7:21 am

Cipla India business chief executive officer and executive vice president Nikhil Chopra said in an emailed statement that the company was launching Cipremi commercially on Wednesday and aims to supply over 80,000 vials within the first month, but did not give details on pricing or dosage.

FDCA advises prudent usage of Tocilizumab and Remdesivir

July 08, 2020 10:32 am

Tocilizumab is to be used in moderate condition when a patient is on oxygen and administering steroids does not improve their condition. Remdesivir, too, is to be administered to moderate condition patients who are on oxygen.